Which anti-CD20 antibody is better in follicular lymphoma?

James O. Armitage, Dan L. Longo

Research output: Contribution to journal › Editorial

5 Scopus citations

Original language	English (US)
Pages (from-to)	1389-1390
Number of pages	2
Journal	New England Journal of Medicine
Volume	377
Issue number	14
DOIs	https://doi.org/10.1056/NEJMe1706154
State	Published - Oct 5 2017

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMe1706154

Cite this

Armitage, J. O., & Longo, D. L. (2017). Which anti-CD20 antibody is better in follicular lymphoma? New England Journal of Medicine, 377(14), 1389-1390. https://doi.org/10.1056/NEJMe1706154

@article{0b9942c80b884432b33d08e6d41ecfff,

title = "Which anti-CD20 antibody is better in follicular lymphoma?",

author = "Armitage, {James O.} and Longo, {Dan L.}",

year = "2017",

month = oct,

day = "5",

doi = "10.1056/NEJMe1706154",

language = "English (US)",

volume = "377",

pages = "1389--1390",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "14",

}

TY - JOUR

T1 - Which anti-CD20 antibody is better in follicular lymphoma?

AU - Armitage, James O.

AU - Longo, Dan L.

PY - 2017/10/5

Y1 - 2017/10/5

UR - http://www.scopus.com/inward/record.url?scp=85030485376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030485376&partnerID=8YFLogxK

U2 - 10.1056/NEJMe1706154

DO - 10.1056/NEJMe1706154

M3 - Editorial

C2 - 28976852

AN - SCOPUS:85030485376

VL - 377

SP - 1389

EP - 1390

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 14

ER -